HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Antunes, M. J. Search for Related Content PubMed PubMed Citation Articles by Antunes, M. J.

The Annals of Thoracic Surgery, Vol 50, 743-747, Copyright © 1990 by The Society of Thoracic Surgeons

ARTICLES

Clinical performance of St. Jude and Medtronic-Hall prostheses: a randomized comparative study

MJ Antunes
Division of Cardiothoracic Surgery, University of the Witwatersrand, Johannesburg, South Africa.

Newer and improved models of mechanical prostheses are regularly added to surgeons' armamentarium. This study was designed to compare the clinical performance of two of the most used current models of mechanical prostheses. From August 1983 through July 1985, 182 white patients were prospectively randomized to implantation of the St. Jude Medical (95 patients) or Medtronic-Hall (87 patients) prostheses. There were 84 mitral, 85 aortic, and 13 double (mitral and aortic) valve replacements. There were no differences between the two groups with regard to sex distribution, age, functional class, emergency operation, and site of implantation. Early mortality was 3.2% for patients with the St. Jude valve and 5.7% for those with the Medtronic-Hall (p = NS). The survivors were followed for 3 to 5 years (mean, 4.2 +/- 0.6 years; cumulative follow-up, 559 patient-years). Late mortality was 7.1%/patient-year for the St. Jude group and 3.2%/patient-year for the Medtronic-Hall group (p less than 0.05). However, the valve-related mortality was equal (1.4%/patient-year) for both groups. Noncardiac causes accounted for most of the difference between the St. Jude and Medtronic-Hall groups (2.5%/patient-year and 0.4%/patient-year, respectively). There were no cases of thrombotic obstruction, whereas serious systemic thromboembolism occurred at the rate of 1.8%/patient- year (5 episodes) for the St. Jude group and 2.5%/patient-year (7 episodes) for the Medtronic-Hall group (p = not significant); there were another nine episodes of systemic embolism that left no sequelae. Three patients (St. Jude, 2; Medtronic-Hall, 1), all of whom had aortic valve replacement, required reoperation (0.5%/patient-year) because of prosthetic endocarditis, with two deaths.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				N. D. Desai and G. T. Christakis Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894. [Full Text]

				V. Kutay, K. Kirali, H. Ekim, and C. Yakut Effects of Giant Left Atrium on Thromboembolism after Mitral Valve Replacement Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 107 - 111. [Abstract] [Full Text] [PDF]

				Y. Wu, R. Gregorio, A. Renzulli, F. Onorati, M. De Feo, G. Grunkemeier, and M. Cotrufo Mechanical heart valves: Are two leaflets better than one? J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1171 - 1179. [Abstract] [Full Text] [PDF]

				N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text]

				W.R. E. Jamieson, R. T. Miyagishima, G. L. Grunkemeier, E. Germann, C. Henderson, G. J. Fradet, L. H. Burr, and S. V. Lichtenstein Bileaflet mechanical prostheses performance in mitral position Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 786 - 794. [Abstract] [Full Text] [PDF]

				A. C. Fiore, H. B. Barner, M. T. Swartz, L. R. McBride, A. J. Labovitz, K. J. Vaca, J. St. Vrain, G. L. Grunkemeier, and G. C. Kaiser Mitral valve replacement: randomized trial of St. Jude and Medtronic Hall prostheses Ann. Thorac. Surg., September 1, 1998; 66(3): 707 - 713. [Abstract] [Full Text] [PDF]

				C. E.E. Kuntze, E. H. Blackstone, and T. Ebels Thromboembolism and mechanical heart valves: a randomized study revisited Ann. Thorac. Surg., July 1, 1998; 66(1): 101 - 107. [Abstract] [Full Text] [PDF]

				W.R. E. Jamieson, A. I. Munro, R. T. Miyagishima, G. L. Grunkemeier, L. H. Burr, S. V. Lichtenstein, and G. F. O. Tyers Multiple mechanical valve replacement surgery comparison of St. Jude Medical and CarboMedics prostheses Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 151 - 159. [Abstract] [Full Text] [PDF]

				T. Abe, K. Kamata, K. Kuwaki, K. Komatsu, and S. Komatsu Ten Years' Experience of Aortic Valve Replacement With the Omnicarbon Valve Prosthesis Ann. Thorac. Surg., April 1, 1996; 61(4): 1182 - 1187. [Abstract] [Full Text]

				C. W. Akins Long-Term Results With the Medtronic-Hall Valvular Prosthesis Ann. Thorac. Surg., March 1, 1996; 61(3): 806 - 813. [Abstract] [Full Text]

				A. E. Fiane, K. Saatvedt, J. L. Svennevig, O. Geiran, K. Nordstrand, and T. Froysaker The CarboMedics Valve: Midterm Follow-up With Analysis of Risk Factors Ann. Thorac. Surg., October 1, 1995; 60(4): 1053 - 1058. [Abstract] [Full Text]

				R. G. Masters, A. L. Pipe, V. M. Walley, and W. J. Keon Comparative results with the St. Jude Medical and Medtronic Hall mechanical valves J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 663 - 671. [Abstract] [Full Text]

				A. C. Fiore, M. T. Swartz, T. G. Sharp, K. A. Kesler, H. B. Barner, K. S. Naunheim, G. L. Grunkemeier, D. A. Moroney, and G. C. Kaiser Double-Valve Replacement With Medtronic-Hall or St. Jude Valve Ann. Thorac. Surg., May 1, 1995; 59(5): 1113 - 1119. [Abstract] [Full Text]

				M. Ibrahim, H. O'Kane, J. Cleland, D. Gladstone, M. Sarsam, and C. Patterson The St. Jude Medical prosthesisA thirteen-year experience J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 221 - 230. [Abstract] [Full Text]